{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:40:10Z","timestamp":1787805610165,"version":"build-2784847793"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS-PI113-01330"],"award-info":[{"award-number":["FIS-PI113-01330"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2014-PROD00032"],"award-info":[{"award-number":["2014-PROD00032"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010573","name":"Stichting Dioraphte","doi-asserted-by":"crossref","award":["VSM 10030200 and 14041401"],"award-info":[{"award-number":["VSM 10030200 and 14041401"]}],"id":[{"id":"10.13039\/501100010573","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"crossref","award":["PIF-UAB"],"award-info":[{"award-number":["PIF-UAB"]}],"id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003043","name":"EMBO","doi-asserted-by":"publisher","award":["ASTF 36-2016"],"award-info":[{"award-number":["ASTF 36-2016"]}],"id":[{"id":"10.13039\/501100003043","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0188191","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T18:24:54Z","timestamp":1511202294000},"page":"e0188191","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of an A\u03b2-antibody fragment on A\u03b2 aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides"],"prefix":"10.1371","volume":"12","author":[{"given":"Laia","family":"Montoliu-Gaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Veerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-4304","authenticated-orcid":true,"given":"Sandra","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"J Hardy","year":"2002","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer\u2019s disease: an emperor in need of clothes","author":"I Benilova","year":"2012","journal-title":"Nature Neuroscience"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"KG Mawuenyega","year":"2010","journal-title":"Science"},{"key":"ref4","first-page":"245","article-title":"Biochemistry and Molecular Biology of Amyloid \u03b2\u2014Protein and the Mechanism of Alzheimer\u2019s Disease","author":"DJ Selkoe","year":"2008","journal-title":"Biochemistry and Molecular Biology of Amyloid \u03b2\u2014Protein and the Mechanism of Alzheimer\u2019s Disease"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal","volume":"110","author":"J Hardy","year":"2009","journal-title":"J Neurochem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"K Blennow","year":"2006","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2174\/1568007054038184","article-title":"Amyloid associated proteins in Alzheimer\u2019s and prion disease","volume":"4","author":"R Veerhuis","year":"2005","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005072-199704000-00001","article-title":"The pathogenesis of senile plaques","volume":"56","author":"DW Dickson","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","article-title":"Apolipoprotein E: far more than a lipid transport protein","volume":"1","author":"RW Mahley","year":"2000","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: from lipid transport to neurobiology","volume":"50","author":"PS Hauser","year":"2011","journal-title":"Prog Lipid Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-2275(20)32449-4","article-title":"Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis","volume":"40","author":"K Winkler","year":"1999","journal-title":"J Lipid Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"EH Corder","year":"1993","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"J-C Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00005-015-0351-0","article-title":"Inflammation in Alzheimer\u2019s Disease and Molecular Genetics: Recent Update","volume":"63","author":"Z-G Zhang","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"Pt 2","key":"ref15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/bj3440375","article-title":"Functional and structural properties of lipid-associated apolipoprotein J (clusterin)","volume":"344","author":"M Calero","year":"1999","journal-title":"Biochem J"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00296787","article-title":"SP-40,40 is a constituent of Alzheimer\u2019s amyloid","volume":"83","author":"NH Choi-Miura","year":"1992","journal-title":"Acta Neuropathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/bj2930027","article-title":"The cerebrospinal-fluid soluble form of Alzheimer\u2019s amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex","author":"J Ghiso","year":"1993","journal-title":"Biochem J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/glia.21004","article-title":"Astrocytic A beta 1\u201342 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins","volume":"58","author":"HM Nielsen","year":"2010","journal-title":"Glia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/glia.22619","article-title":"Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro","volume":"62","author":"SD Mulder","year":"2014","journal-title":"Glia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI112130","article-title":"Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system","volume":"76","author":"JK Boyles","year":"1985","journal-title":"J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0005-2760(87)90295-5","article-title":"Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins","volume":"917","author":"RE Pitas","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ncpneuro0355","article-title":"Mechanisms of Disease: astrocytes in neurodegenerative disease","volume":"2","author":"NJ Maragakis","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"M V. Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref24","article-title":"Review: Astrocytes in Alzheimer\u2019s disease and other age-associated dementias; a supporting player with a central role","author":"CJ Garwood","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1074\/jbc.M114.618157","article-title":"Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity","volume":"290","author":"W Fu","year":"2015","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-016-0098-z","article-title":"Accumulation of amyloid-\u03b2 by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons","volume":"11","author":"S S\u00f6llvander","year":"2016","journal-title":"Mol Neurodegener"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"S Salloway","year":"2014","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/BJ20101712","article-title":"An anti-A\u03b2 (amyloid \u03b2) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing A\u03b2 oligomers from the amyloid pathway","volume":"437","author":"M Mar\u00edn-Argany","year":"2011","journal-title":"Biochem J"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4161\/mabs.25424","article-title":"Early intervention in the 3xTg-AD mice with an amyloid \u03b2-antibody fragment ameliorates first hallmarks of alzheimer disease","volume":"5","author":"L Gim\u00e9nez-Llort","year":"2013","journal-title":"MAbs"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4161\/mabs.25428","article-title":"Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid \u03b2 antibody fragment","volume":"5","author":"G Esquerda-Canals","year":"2013","journal-title":"MAbs"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-122377","article-title":"In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-\u03b2 pathology","volume":"36","author":"SP Handattu","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1161\/01.ATV.0000174589.70190.e2","article-title":"An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice","volume":"25","author":"M Navab","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/11594190-000000000-00000","article-title":"Apolipoprotein E mimetics and cholesterol-lowering properties","volume":"11","author":"OF Sharifov","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2010.09.030","article-title":"Two adjacent domains (141\u2013150 and 151\u2013160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects","volume":"213","author":"G Nayyar","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.atherosclerosis.2009.07.019","article-title":"Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)","volume":"208","author":"G Datta","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tcm.2007.12.006","article-title":"The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis","volume":"18","author":"M Navab","year":"2008","journal-title":"Trends Cardiovasc Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4161\/mabs.25382","article-title":"Elongation of the C-terminal domain of an anti-amyloid \u03b2 single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency","volume":"5","author":"G Rivera-Hern\u00e1ndez","year":"2013","journal-title":"MAbs"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/glia.20822","article-title":"Binding and uptake of A beta1-42 by primary human astrocytes in vitro","volume":"57","author":"HM Nielsen","year":"2009","journal-title":"Glia"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.7717\/peerj.73","article-title":"Ammonium hydroxide treatment of A\u03b2 produces an aggregate free solution suitable for biophysical and cell culture characterization","volume":"1","author":"TM Ryan","year":"2013","journal-title":"PeerJ"},{"key":"ref40","article-title":"Understanding the contribution of disulphide bridges to the folding and misfolding of an anti-A\u03b2 scFv","author":"L Montoliu-Gaya","year":"2017","journal-title":"Protein Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3233\/JAD-2011-111421","article-title":"Methods for analysis of amyloid-\u03b2 aggregates","volume":"28","author":"KA Bruggink","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.1106420108","article-title":"Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions","volume":"108","author":"J Chen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbamem.2010.10.011","article-title":"Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR","volume":"1808","author":"VK Mishra","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of Amyloid-\u03b2 Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease","volume":"8","author":"R Deane","year":"2009","journal-title":"CNS Neurol Disord\u2014Drug Targets"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/alzrt135","article-title":"Apolipoprotein E, amyloid-\u00df clearance and therapeutic opportunities in Alzheimer\u2019s disease","volume":"4","author":"A Kline","year":"2012","journal-title":"Alzheimers Res Ther"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal apoE\/A\u03b2 association in physiological conditions","volume":"110","author":"PB Verghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Q Jiang","year":"2008","journal-title":"Neuron"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"21591","DOI":"10.1074\/jbc.M115.652008","article-title":"Combined Liver X Receptor\/Peroxisome Proliferator-activated Receptor \u03b3 Agonist Treatment Reduces Amyloid \u03b2 Levels and Improves Behavior in Amyloid Precursor Protein\/Presenilin 1 Mice","volume":"290","author":"R Skerrett","year":"2015","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"C-C Liu","year":"2013","journal-title":"Nat Rev Neurol. Nature Publishing Group"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/NEN.0b013e31823a44f4","article-title":"Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy","volume":"70","author":"J Magalh\u00e3es","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"10843","DOI":"10.1073\/pnas.162228299","article-title":"Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer\u2019s disease","volume":"99","author":"RB DeMattos","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bbadis.2013.04.012","article-title":"Extracellular chaperones prevent A\u03b242-induced toxicity in rat brains","volume":"1832","author":"R Cascella","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1074-5521(96)90183-0","article-title":"An ApoE-Abeta inhibition complex in Abeta fibril extension","volume":"3","author":"SJ Wood","year":"1996","journal-title":"Chem Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1021\/bi961074j","article-title":"Seeding of A\u03b2 Fibril Formation Is Inhibited by All Three Isotypes of Apolipoprotein E","volume":"35","author":"SJ Wood","year":"1996","journal-title":"Biochemistry"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1021\/bi980550y","article-title":"Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer\u2019s beta-amyloid fibril formation in vitro","volume":"37","author":"H Naiki","year":"1998","journal-title":"Biochemistry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2012.04.021","article-title":"The role of astrocytes in amyloid \u03b2-protein toxicity and clearance","volume":"236","author":"DR Thal","year":"2012","journal-title":"Exp Neurol"},{"key":"ref57","article-title":"Microglia show altered morphology and reduced arborization in human brain during aging and Alzheimer\u2019s disease","author":"DS Davies","year":"2016","journal-title":"Brain Pathol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1567205013666160229112911","article-title":"Complex and differential glial responses in Alzheimer\u2019s disease and ageing","volume":"13","author":"JJ Rodr\u00edguez","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","article-title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","volume":"69","author":"S Ostrowitzki","year":"2012","journal-title":"Arch Neurol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"RB DeMattos","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1523\/JNEUROSCI.22-18-07873.2002","article-title":"Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy","volume":"22","author":"BJ Bacskai","year":"2002","journal-title":"J Neurosci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0188191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T18:36:47Z","timestamp":1659897407000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0188191"}},"subtitle":[],"editor":[{"given":"Israel","family":"Silman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,20]]},"references-count":61,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0188191","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,20]]}}}